Tom Gaunt, partner and head of IP at Lewis Silkin (pictured), said the team has been in “growth mode” over the last couple of ...

As revenue reporting season hits full stride, firms have made a point of highlighting the successes of their IP teams as they ...

GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...